Explore Our 2025 ASCO Annual Meeting Coverage
Stay informed with expert insights and in-depth analysis from the 2025 ASCO Annual Meeting. AJMC’s coverage brings you the latest in oncology research, payer-relevant takeaways, and interviews with leading voices in the field.
Latest News
View All
EHA 2025 Late-Breakers Reflect Diversity of Hematology Topics, From RedirecTT-1 Combo to Frailty Scales
Discussing Sexuality, Mental Health With AYA Patients Amid the Hematological Treatment Journey
EHA Plenary Abstracts Zoom in From Investigational Drugs to Molecular Signatures
The Growing Role of AI and Other Technology in Cancer Care: Coral Omene, MD, PhD
Unaddressed Adverse Effects Undermine Patient Confidence in Lymphoma, CLL Care Plans: Lorna Warwick
Phase 3 POLARGO Trial Shows Survival Benefit of Polatuzumab-Based Regimen in R/R DLBCL: Matthew Matasar, MD
Lower Socioeconomic Status Tied to Worse Quality of Life in R/R Multiple Myeloma: Francesco Sparano, MSc
Is the Employer Health Care Tax Exclusion Safe? Kerris Willis Shares Insight From American Benefits Council
Pediatric Atopic Dermatitis Linked to Allergy Development
Addressing Myasthenia Gravis Diagnostic Delays and Access Barriers: Marla Black Morgan, MD
AI-Based Tool for Classifying Acute Leukemia Subtypes Shows Promise in Global Study: Merlin Engelke, MS
Dual-Biomarker Approach Best for Equitable Kidney Disease Risk Assessment, New Data Find
Data Collection Helps the Delivery of Equitable Value-Based Cancer Care: Coral Omene, MD, PhD
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Barriers to Optimal NF1-PN Care for Patients
Working With Policy Makers to Effectively Implement Biosimilars
Dry Eye Disease: Pathophysiology, Impact, and Standard of Care
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
The Growing Role of AI and Other Technology in Cancer Care: Coral Omene, MD, PhD
Unaddressed Adverse Effects Undermine Patient Confidence in Lymphoma, CLL Care Plans: Lorna Warwick
Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD
Phase 3 POLARGO Trial Shows Survival Benefit of Polatuzumab-Based Regimen in R/R DLBCL: Matthew Matasar, MD
Phase 3 IRAKLIA Trial Compares On-Body vs IV Isatuximab in RRMM: Xavier Leleu, MD, PhD
Lower Socioeconomic Status Tied to Worse Quality of Life in R/R Multiple Myeloma: Francesco Sparano, MSc
EHA 2025 Late-Breakers Reflect Diversity of Hematology Topics, From RedirecTT-1 Combo to Frailty Scales
Unaddressed Adverse Effects Undermine Patient Confidence in Lymphoma, CLL Care Plans: Lorna Warwick
Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD
Discussing Sexuality, Mental Health With AYA Patients Amid the Hematological Treatment Journey
Outcomes for Hospitals Participating in More- and Less-Mature ACOs
Factors Associated With Unplanned Admissions Among Patients With Chronic Conditions
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Weighing Drug Costs and Patient Values in Cancer Care
Cancer Care Innovations Abound, but Access and Equity Are Ongoing Challenges
Translating Best Practices and Ensuring Equitable Care as the Treatment Landscape Evolves
Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits
Novel Therapies and Emerging Strategies for HR+/HER2- Metastatic Breast Cancer and the Impact on Patient Outcomes
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodies and CAR T-Cell Therapy
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
Novel Agents as Proactive Approaches to Addressing Food Allergy: The Role of the Pharmacist in Guiding Optimal Treatment
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
Navigating Next-Generation Therapies for the Management of Acid-Related Disorders
